戻る Agendas
Concurrent Breakout Session 2B: Bayesian Evidence Synthesis
Session Chair(s)
John W. Seaman, PHD
Professor of Statistics
Baylor University, United States
Speaker(s)
Meta-analysis in Safety Data
Mark Levenson, PHD
FDA, United States
Director, Division of Biometrics VII, Office of Biostatistics, OT, CDER
Bayesian Meta-Analysis in Drug Safety Evaluation
Amy Xia, PHD
Amgen Inc., United States
Vice President, Center for Design and Analysis
Bayesian Network Meta-analysis
Bradley P. Carlin, PHD, MS
PharmaLex, United States
Senior Advisor, Data Science and Statistics
Q&A Panel Discussion
Panel Discussion
All Session Speakers, United States
John Scott, PHD, MA
FDA, United States
Division Director, Office of Biostatistics, CBER